Maiden Pharmaceuticals, linked to cough syrups associated with child deaths in Gambia, denied tampering with test samples or bribing officials. An investigation by the state of Haryana s Food and Drug Administration is probing whether a state drug regulator was bribed to switch samples tested by the Indian government, contradicting WHO findings.
An investigator with the state of Haryana's Food and Drug Administration told on Friday he was close to finishing a probe into whether a state drug regulator was bribed to switch samples
India probe into bribery claim in toxic syrup tests nears completion thefrontierpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thefrontierpost.com Daily Mail and Mail on Sunday newspapers.
Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or
India's Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or bribed officials to do so, as alleged in a complaint under investigation by local health officials. An investigator with the state of Haryana's Food and Drug Administration told Reuters on Friday he was close to finishing a probe into whether a state drug regulator was bribed to switch samples, tested by the Indian government, that contradicted the World Health Organization's findings of toxic substances in the cough syrups. "I have never changed the sample," Maiden founder Naresh Kumar Goyal told Reuters.